Your browser doesn't support javascript.
loading
Late-Life Depression versus Amnestic Mild Cognitive Impairment: Alzheimer's Disease Incidence in 4 Years of Follow-Up.
Lauriola, Michele; Mangiacotti, Antonio; D'Onofrio, Grazia; Cascavilla, Leandro; Paris, Francesco; Ciccone, Filomena; Greco, Monica; Paroni, Giulia; Seripa, Davide; Greco, Antonio.
Afiliação
  • Lauriola M; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Mangiacotti A; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • D'Onofrio G; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italygraziadonofrio@libero.it.
  • Cascavilla L; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Paris F; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Ciccone F; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Greco M; Clinical Unit of Internal Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy.
  • Paroni G; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Seripa D; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Greco A; Complex Unit of Geriatrics, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Dement Geriatr Cogn Disord ; 46(3-4): 140-153, 2018.
Article em En | MEDLINE | ID: mdl-30199883
ABSTRACT
BACKGROUND/

AIM:

The aim of the study was to evaluate the prognostic power of late-life depression (LLD) compared with amnestic mild cognitive impairment (aMCI) for the onset of Alzheimer's disease (AD) within 4 years of follow-up.

METHODS:

We estimated the incidence of AD in 60 patients presenting with aMCI, 115 patients suffering of LLD treated with antidepressants with good compliance, and 66 healthy control (HC) patients, followed for 4 years.

RESULTS:

The risk to develop AD, within 4 years, was 68.33% for aMCI and 49.57% for LLD. In AD patients 5.60% deteriorated without depression, and 72.20% deteriorated with depression after 4 years of follow-up (p < 0.0001). No HC patients deteriorated to AD or any other dementia type.

CONCLUSION:

In our results, aMCI was the first predictive condition that increased the risk to develop AD. Depression is a potentially preventable medical condition across the lifespan and may be a modifiable risk factor.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Disfunção Cognitiva / Transtornos da Memória / Testes Neuropsicológicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Disfunção Cognitiva / Transtornos da Memória / Testes Neuropsicológicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article